Atomwise
Artificial intelligence for drug discovery.
San Francisco, United States · Founded 2012 · $123.0M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2012
- Business Model
- B2B
- Website
- atomwise.com
- Total Funding
- $123.0M
- Last Round
- $123.0M Series BAug 2020
- Rounds
- 1
About
Numerion Labs is an AI-native company accelerating the discovery of life-saving medicines through the development and use of cutting-edge machine learning algorithms. The company unites computational chemistry, structural biology, and medicinal chemistry to pioneer the next generation of AI-driven drug discovery platforms.
Summary
Atomwise is a Biotech company based in San Francisco, United States, founded in 2012. It has raised $123.0M in total across 1 round, most recently a $123.0M Series B round in Aug 2020. Investors include B Capital Group.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2020
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.